Authors : Dr. Kiran S. S.; Dr. Sudheesh K. P.; Dr. Neethu Tharol; Dr. Harishkiran G. S.

Volume/Issue : Volume 10 - 2025, Issue 11 - November

Google Scholar : https://tinyurl.com/y6nhdedc

Scribd : https://tinyurl.com/4e5yc5bw

DOI : https://doi.org/10.38124/ijisrt/25nov1367

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : Rajayakshma is mentioned as one of the Ashthamahagada by Acharya Charaka and also known as the "king of the disease" Due to its multisystem involvement and varied symptoms. Rajayakshma has been linked to numerous immunodeficiency syndromes. However, a closer look at the symptoms reveals that it more closely resembles a multisystem respiratory disease. Swasthya Raksha is a formulation conceptualized by All India Institute of Ayurveda, New Delhi & prepared by Indian Medicine Pharmaceutical Corporation Limited, to combat the post hostile effects of COVID 19. In the present period, pulmonary tuberculosis can be linked to Rajyakshma, which affects the Pranavaha Srotas. Pulmonary Tuberculosis (PTB) is one among such conditions. PTB may be compared with Rajayakshma in Ayurveda. Use of Rasayana drug as an adjunct with Anti Tubercular Drugs provides better physical and mental wellbeing to the patients. Swasthya Raksha Kit consists of Chyavanaprash, Rasayanchurnavati, Swasthyaraksha Tea and Anutaila. Although the pathophysiology of Rajayakshma and pulmonary tuberculosis differ, their clinical profiles are remarkably similar.  Methods: 30 known cases of Tuberculosis patients has been selected based on inclusion and exclusion criteria from Taluk Government Hospital, Badami and Swasthya Raksha kit were advised for one month and were asked to come for follow up after one month this was continued for a total of 90 days and the symptoms were assessed before and after completion of 90 days.  Results: There were significant changes in the symptoms of Rajaykshama/PTB patients when Swasthya Raksha kit were used as an adjuvant with anti-tubercular medicines for 90 days.  Interpretation and Conclusion: Addition of Swastha Raksha kit with contemporary medicines of PTB gives relief from symptoms and complications of medicines and further large-scale studies is to be conducted to understand this in a better way.

Keywords : Rajayakshma, Yakshma, Jwara, Kshaya, Roga, Pulmonary Tuberculosis, Swasth Raksha kit.

References :

1. Sudre P, ten Dam G, Kochi A. Tuberculosis: a global overview of the situation today. Bull World Health Organ. 1992;70(2):149-59. PMID: 1600578; PMCID: PMC2393290.
2. Chauhan A, Parmar M, Dash GC, Solanki H, Chauhan S, Sharma J, Sahoo KC, Mahapatra P, Rao R, Kumar R, Rade K, Pati S. The prevalence of tuberculosis infection in India: A systematic review and meta-analysis. Indian J Med Res. 2023 Feb-Mar;157(2&3):135-151. doi: 10.4103/ijmr.ijmr_382_23. PMID: 37202933; PMCID: PMC10319385.
3. Maher D, Raviglione M. Global epidemiology of tuberculosis. Clinics in chest medicine. 2005 Jun 1;26(2):167-82.
4. Sia IG, Wieland ML. Current concepts in the management of tuberculosis. InMayo Clinic Proceedings 2011 Apr 1 (Vol. 86, No. 4, pp. 348-361). Elsevier.
5. Yadavaji Trikamaji, editor. Charaka Samhita of Charaka, Nidana Sthana, chapter 6, verse no.4. reprinted, Varanasi; Chowkhambha Sanskrit Series, 2008; (1): 193.
6. Shirke, V. (2021). Rajayakshma: Ayurvedic classical literature review.: Array. Ayurline: International Journal of Research in Indian Medicine, 5(03). https://doi.org/10.52482/ayurline.v5i03.551
7. Debnath PK, Chattopadhyay J, Ghosal D, Bhattacharya P. Immunomodulatory Role of Ayurvedic Rasayan for Quality of Life. International Nat Conf 1998. 38.
8. Bala K, Goyal M. Ayurvedic approach in the management of Pulmonary Tuberculosis wsr to Rajayakshma-A Case Report. Journal of Ayurveda and Integrated Medical Sciences. 2025 Aug 25;10(9):316-23.
9. Debnath PK, Chattopadhyay J, Mitra A, Adhikari A, Alam MS, Bandopadhyay SK, Hazra J. Adjunct therapy of Ayurvedic medicine with anti tubercular drugs on the therapeutic management of pulmonary tuberculosis. J Ayurveda Integr Med. 2012 Jul;3(3):141-9. doi: 10.4103/0975-9476.100180. PMID: 23125511; PMCID: PMC3487240.
10. Sharma R, Martins N, Kuca K, Chaudhary A, Kabra A, Rao MM, Prajapati PK. Chyawanprash: A Traditional Indian Bioactive Health Supplement. Biomolecules. 2019 Apr 26;9(5):161. doi: 10.3390/biom9050161. PMID: 31035513; PMCID: PMC6571565.
11. Balkrishna A, Rastogi S, Kharayat B, Tomer M, Varshney Y, Singh K, Kumari P, Dev R, Srivastava J, Haldar S, Varshney A. Anu taila, an herbal nasal drop, suppresses mucormycosis by regulating host TNF-α response and fungal ergosterol biosynthesis. J Appl Microbiol. 2022 Apr;132(4):3355-3374. doi: 10.1111/jam.15451. Epub 2022 Feb 6. PMID: 35025137.